Myriapod Archivi - Seite 4 von 4 - Diatech

11 04, 2019

Enrico Mini et al., RNA sequencing reveals PNN and KCNQ1OT1as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy

Diatech Pharmacogenetics2019-04-11T11:26:55+02:00

14 02, 2019

Lorenza Rimassa et al., Phase 2 study of tivantinib and cetuximab in KRAS wild-type metastatic colorectal cancer patients with acquired resistance to EGFR inhibitors and emergence of MET overexpression: lesson learned for future trials with EGFR/MET dual inhibition

Diatech Pharmacogenetics2019-02-14T09:32:18+01:00

15 11, 2018

Matteo Fassan et. al, miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis

Diatech Pharmacogenetics2018-11-15T14:42:45+01:00

10 08, 2017

Gianni Bussolati et al., Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples. Plos One

Diatech Pharmacogenetics2017-08-10T10:35:58+02:00

14 06, 2016

Riccardo Giannini et al., EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center. Oncology Reports

Diatech Pharmacogenetics2016-06-14T11:50:34+02:00